ISRCTN74486450已完成2 期
PTH(1-34) for the primary prevention of post-surgical hypocalcemia: the THYPOS trial
niversità Campus Bio-Medico di Roma0 个研究点目标入组 22 人开始时间: 2016年4月12日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18 and over
- •2. Patients with a formal surgical indication for thyroidectomy.
排除标准
- •1. Aged under 18 years
- •2. Pregnancy
- •3. Renal failure (glomerular filtration rate < 30 mL/min)
- •4. Hypersensitivity to the active substance or excipients
- •5. Any prior parathyroid pathology
- •6. Preexisting hypercalcemia
- •7. Metabolic bone disease other than osteoporosis
- •8. Ongoing therapy for osteoporosis
- •9. In the last 6 months administration of calcitonin
- •10. Systemic corticosteroids, estrogens, raloxifene, fluoride, lithium, loop or thiazide diuretics, aromatase inhibitors or other drugs that could interfere with calcium metabolism
- •11. History of skeletal malignancies (primary or metastatic)
- •12. Active or recent urolithiasis
- •13. Unexplained elevation of serum alkaline phosphatase levels
- •14. Prior radiation therapy involving the skeleton, serum magnesium levels below the lower limits or above the upper limits of normal
研究者
相似试验
进行中（未招募）
1 期
SE OF TERIPARATIDE TO PREVENT HYPOCALCEMIA IN POST SURGICAL PATIENTSPOST SURGICAL HYPOCALCEMIAMedDRA version: 20.0Level: PTClassification code 10033557Term: PalpitationsSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10021097Term: HypotensionSystem Organ Class: 10047065 - Vascular disordersMedDRA version: 20.0Level: PTClassification code 10037087Term: PruritusSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2016-000481-32-ITIVERSITÀ CAMPUS BIO-MEDICO DI ROMA26
尚未招募
1 期
A single immediate postoperative prophylactic intravesical instillation of Pirarubicin following transurethral resection of non-muscle invasive bladder cancernon-muscle invasive bladder cancer (pTa and low grade)JPRN-UMIN000004378Kobe University Hospital80
进行中（未招募）
1 期
Does postoperative treatment with parathyroidea hormone Forteo®improve the disability inelderly patients undergoing spinal stabilization fusion surgery comparedwith patients treated with placebo. If that is the case, is there a correlationbetween improvement of disability and solid osseous healing?MedDRA version: 14.1Level: LLTClassification code 10041597Term: Spinal stenosis of lumbar regionSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersSpinal stenosisEUCTR2011-006152-36-DKMiddelfart Rygsektor100
尚未招募
不适用
Clinical studies for the prevention of postoperative delirium in oral cancerOral cancer,DeliriumJPRN-UMIN000042066Tokyo Medical and Dental University1,600
已完成
2 期
Systemic corticosteroid for prophylaxis of postembolization syndrome after Hepatic Transarterial Chemoembolization in patients with hepatocellular carcinoma: A randomized, double-blinded, placebo controlled trialHepatocellular carcinoma patients who eligible for Tranarterial chemoembolization.HCC TACE prophylaxis steroidTCTR20170906004/A100